Another term for the Roux-en-Y gastric bypass, the Roux bypass is highly regarded for its effectiveness in helping patients lose weight and improve health conditions related to obesity. Named after the French surgeon César Roux, this procedure is a combination of both restrictive and malabsorptive techniques. It requires a lifetime commitment to dietary changes, exercise, and regular follow-up with healthcare professionals.

The "fat jab," also known as Saxenda or liraglutide, is an injectable weight-loss drug that has been approved for use on the NHS in the UK for individuals struggling with obesity. It is intended for use in conjunction with a reduced-calorie diet and increased physical activity. The medication helps control appetite, leading to weight loss. It is typically prescribed to those with a BMI over 30 or individuals with weight-related health problems.

Endoscopic Sleeve Gastroplasty (ESG) is a non-surgical weight-loss procedure where a gastroenterologist uses an endoscope to stitch the stomach into a smaller size, reducing its capacity. Unlike traditional bariatric surgery, ESG is performed through the mouth and doesn’t involve cutting or removing any part of the stomach. Recovery is quicker, and the procedure is reversible, but the weight loss achieved is typically less significant than with RNY or gastric sleeve surgery.

The prognosis for gastrointestinal (GI) cancer depends on the type and stage of cancer at diagnosis. Early-stage GI cancers, including stomach, colon, and esophageal cancers, have better survival rates when treated with surgery, chemotherapy, or radiation. Advanced-stage cancers are more difficult to treat and often require palliative care.

The prognosis for gastrointestinal (GI) cancer depends on the type and stage of cancer at diagnosis. Early-stage GI cancers, including stomach, colon, and esophageal cancers, have better survival rates when treated with surgery, chemotherapy, or radiation. Advanced-stage cancers are more difficult to treat and often require palliative care.

Gastro refers to gastrointestinal conditions broadly, while gastritis specifically refers to inflammation of the stomach lining. Gastro disorders can include a range of conditions affecting the entire digestive tract, whereas gastritis is a localized condition of the stomach.

A weight-loss shot refers to medications like Wegovy (semaglutide), which are injected to aid weight loss. These drugs work by mimicking a hormone that targets areas of the brain responsible for appetite, helping individuals feel full with less food. These injections are typically prescribed for patients with obesity or related health issues.

A mass in the stomach refers to an abnormal growth or lump, which could be benign (non-cancerous) or malignant (cancerous). It may present with symptoms such as pain, bloating, or unexplained weight loss. Diagnostic tests like imaging or a biopsy are essential for determining the nature of the mass and whether surgical removal or further treatment is required.

After sleeve gastrectomy, patients follow a specific diet to help the stomach heal and ensure success in weight loss. The diet starts with liquids, followed by pureed foods, and eventually soft foods before transitioning to solid foods. High-protein, low-fat, and low-sugar meals are critical, along with small, frequent portions.

Gastric sleeve results are typically impressive, with patients losing 50-60% of their excess body weight within the first year. The surgery also leads to improvements in obesity-related conditions like diabetes, hypertension, and sleep apnea. Long-term success depends on the patient’s ability to maintain a healthy lifestyle post-surgery.